IXICO has reported interim results for the 6-months to March 2026 (1H26) in-line with the recent trading update. Revenues increased 23% YoY to £3.9m and gross profit increased 32%, driven by solid margin improvement. The adjusted EBITDA loss improved, supported by increased gross profit offset by targeted investments. IXICO’s order book has strengthened significantly and now provides 95% visibility on our FY26E revenue forecast of £7.5m. The company is progressing its new TechBio strategy, havin ....
